Minister Warken Announces Autumn Distribution of Medications
In a recent press conference, German Health Minister Nina Warken addressed concerns about the availability of medicines, particularly children's medications, during the fall and winter seasons. Warken reassured that the supply of drugs is guaranteed, with improvements in the situation compared to previous years. She acknowledged public concerns, expressing understanding and empathy. The Health Minister highlighted steps taken by the previous government, including the enactment of the Anti-Shortage Act in 2023. This law mandated several months' worth of stocks for frequently used medicines as a safety buffer. Warken also announced plans to implement a reform to give pharmacies more flexibility in exchanging suitable available medicines, ensuring a smooth supply chain and addressing potential shortages promptly. On a broader scale, Warken discussed the drug supply receiving significant attention on both a national and European level. She mentioned that EU regulations are expected to strengthen the production location of drugs in Europe, making deliveries more attractive for manufacturers. The Anti-Shortage Law has relaxed price rules to facilitate these deliveries. However, no new information was provided regarding the stability of medicine availability for fall and winter, the guarantee of drug supply, the improvement in the situation with children's medications, or the mandatory stocks for frequently used medicines. Warken concluded the conference by stating that appropriate measures can be taken promptly in case of drug shortages, reassuring the public of her commitment to maintaining a stable and secure drug supply.
Read also:
- Inadequate supply of accessible housing overlooks London's disabled community
- Strange discovery in EU: Rabbits found with unusual appendages resembling tentacles on their heads
- Duration of a Travelling Blood Clot: Time Scale Explained
- Fainting versus Seizures: Overlaps, Distinctions, and Proper Responses
